- home
- about us
- Investment Approach
- Client Service Approach
- Market Analysis Summary
- Mission Statement
- Value Proposition
- Team Biographies
- Firm ADV PDFs
- Form CRS
- Firm Brochure-Part 2A of Form ADV
- Brochure Supplement Amit Stavinsky
- Brochure Supplement Frank Parks
- Brochure Supplement Dominick Savo
- Brochure Supplement Richard Mason
- Brochure Supplement Joe Estes
- Brochure Supplement Jonathan Ezra
- Statement Of Financial Strength
- Job Opportunities
- Letter to Clients
- member log-in
- contact us
Latest News about SNY
Recent news which mentions SNY
Two Down With Sanofi Bowing Out From Horizon Buyout Talks, Amgen Agrees To Buy For $116.5/Share
December 12, 2022
From Benzinga
Amgen reportedly in talks to buy Horizon Therapeutics
December 12, 2022
From MarketWatch
Will This Potential Approval Be a Winner for Sanofi's Shareholders?
December 09, 2022
From Motley Fool
France Health Body Advises Unfavorable Opinion Regarding Valneva's COVID-19 Vaccine
December 08, 2022
From Benzinga
This Monster Dividend Stock Isn't Done Growing
December 08, 2022
From Motley Fool
Revolution Medicines Regains Global Rights To Mid-Stage Cancer Program As Sanofi Terminates Collaboration
December 08, 2022
From Benzinga
Fusion Fuel (HTOO) Stock Is Up 11% on HUGE Deal News
December 07, 2022
From InvestorPlace
Why Is TransCode Therapeutics (RNAZ) Stock Up 148% Today?
December 07, 2022
From InvestorPlace
SNY Stock Alert: Why 1 Analyst Says Zantac Ruling Is ‘Best-Case Scenario’ for Drugmakers
December 07, 2022
From InvestorPlace
From Benzinga
From Benzinga
GSK and Sanofi shares surge after Florida ruling dismisses Zantac lawsuits in what one analyst describes as ‘best-case scenario’
December 07, 2022
From MarketWatch
These 3 Stocks Escaped Tuesday's Market Downdraft
December 06, 2022
From Motley Fool
Why GSK Plc And Sanofi SA Stock Are Shooting Higher
December 06, 2022
From Benzinga
From Benzinga
The S&P 500 is on the cusp of breaking through a level that might spell the end of the bear market
December 01, 2022
From MarketWatch
Why Horizon Therapeutics Stock Is Skyrocketing Today
November 30, 2022
From Motley Fool
Why Is Horizon Therapeutics (HZNP) Stock Up 30% Today?
November 30, 2022
From InvestorPlace
From Motley Fool
UK Drug Regulator Warns Of Severe Eye Reactions Associated With Sanofi/Regeneron's Dupixent
November 30, 2022
From Benzinga
From Benzinga
Horizon Therapeutics Shares Jump On Confirmation Of Takeover Talks With Several Large Companies
November 30, 2022
From Benzinga
First Drug That Can Delay Onset of Type 1 Diabetes Gets FDA Approval After Multiple Regulatory Hurdles
November 18, 2022
From Benzinga
Europe Approves Sanofi's Enjaymo For Rare Form Of Anemia
November 17, 2022
Tickers
SNY
From Benzinga
Can This Company's Research Help Transform Regenerative Medicine As Its Lead Product Receives FDA IND Approval?
November 14, 2022
From Benzinga
2 Top Biotech Stocks to Buy in November
November 12, 2022
From Motley Fool
Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster
November 10, 2022
From Benzinga
Europe Approves AstraZeneca-Sanofi Partnered Antibody To Prevent RSV Infection In Infants
November 04, 2022
From Benzinga
Why Is Provention Biosciences (PRVB) Stock Up 25% Today?
November 03, 2022
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.